Weekly Recap | XTALPI +2.11%, chairman buying at a range lowWeekly Review·Oct 24, 2026 at 05:17 AM02228+3.25%
Weekly Recap | XTALPI -14.08%, 52-week low then modest reboundWeekly Review·Oct 17, 2026 at 05:41 AM02228+3.25%
Weekly Recap | XTALPI -10.91%, most brokers rate it buyWeekly Review·Oct 10, 2026 at 05:20 AM02228+3.25%
Weekly Recap | XTALPI +3.92%, consensus target above spotWeekly Review·Oct 3, 2026 at 05:25 AM02228+3.25%
Weekly Recap | XTALPI -8.77%, large-lot flow turns net sellerWeekly Review·Sep 26, 2026 at 05:13 AM02228+3.25%
Weekly Recap | XTALPI +17.34%, Stanford AI drug dealWeekly Review·Sep 19, 2026 at 07:48 AM02228+3.25%
Weekly Recap | XTALPI -2.94%, interim net loss hits RMB 224.94mWeekly Review·Sep 12, 2026 at 05:31 AM02228+3.25%
Weekly Recap | XTALPI -1.48%, most brokers rate it buyWeekly Review·Sep 5, 2026 at 05:06 AM02228+3.25%
Weekly Recap | XTALPI +3.05%, most brokers rate it buyWeekly Review·Aug 29, 2026 at 07:41 AM02228+3.25%
Weekly Recap | XTALPI -2.65%, AI surge overshadowed by headline lossWeekly Review·Aug 22, 2026 at 04:05 AM02228+3.25%
